Thrombocytopenic purpura as adverse reaction to recombinant hepatitis B vaccine
Abstract
Three cases of immune thrombocytopenic purpura after the first
dose of recombinant hepatitis B vaccine occurred in infants under 6 months of age. Other possible causes of this condition were excluded.
Antiplatelet antibodies were present. A defect in platelet production
was excluded in two children. Corticosteroid treatment was effective.
Subsequent administration of other vaccines (against polio, diphtheria,
and tetanus) did not cause relapse of thrombocytopenia.
Full Text
The Full Text of this article is available as a PDF (51K).
Selected References
These references are in PubMed. This may not be the complete list of references from this article.
- Herroelen L, de Keyser J, Ebinger G. Central-nervous-system demyelination after immunisation with recombinant hepatitis B vaccine. Lancet. 1991 Nov 9;338(8776):1174–1175. [PubMed] [Google Scholar]
- Lilic D, Ghosh SK. Liver dysfunction and DNA antibodies after hepatitis B vaccination. Lancet. 1994 Nov 5;344(8932):1292–1293. [PubMed] [Google Scholar]
- Martínez E, Domingo P. Evans's syndrome triggered by recombinant hepatitis B vaccine. Clin Infect Dis. 1992 Dec;15(6):1051–1051. [PubMed] [Google Scholar]
- Poullin P, Gabriel B. Thrombocytopenic purpura after recombinant hepatitis B vaccine. Lancet. 1994 Nov 5;344(8932):1293–1293. [PubMed] [Google Scholar]
- Tazzari PL, Ricci F, Vianelli N, Tassi C, Belletti D, Pierri I, Gugliotta L, Gobbi M, Conte R. Detection of platelet-associated antibodies by flow cytometry in hematological autoimmune disorders. Ann Hematol. 1995 May;70(5):267–272. [PubMed] [Google Scholar]
